Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: Implication for post-transplantation toll-like receptor ligand-based immunotherapy

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 10, 2014, Pages 1501-1507

  Charrier, Emily ^a,b   Cordeiro, Paulo ^a   Brito, Rose Marie ^a   Harnois, Michaël ^a,b   Mezziani, Samira ^a   Herblot, Sabine ^a   Le Deist, Françoise ^a,b   Duval, Michel ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cord blood transplantation; Interferon alpha; Plasmacytoid dendritic cells; Toll like receptor (TLR) 9 agonist

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST; CPG ODN 2216; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIBODY; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PLASMACYTOID DENDRITIC CELL; PRESCHOOL CHILD; PROPHYLAXIS; SCHOOL CHILD; T LYMPHOCYTE; YOUNG ADULT; AGONISTS; ALLOTRANSPLANTATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL COUNT; CELL PROLIFERATION; DENDRITIC CELL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GRAFT VS HOST DISEASE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LONGITUDINAL STUDY; PATHOLOGY;

ADOLESCENT; ANTIGENS, CD; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL PROLIFERATION; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INTERFERON-ALPHA; LEUKEMIA; LONGITUDINAL STUDIES; MALE; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 9; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84912087439     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.06.007     Document Type: Article

References (38)

1. Mathan T.S., Figdor C.G., Buschow S.I. Human plasmacytoid dendritic cells: from molecules to intercellular communication network. Front Immunol 2013, 4:372.
2. Tel J., Schreibelt G., Sittig S.P., et al. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 2013, 121:459-467.
3. Remberger M., Sundberg B. Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study. Biol Blood Marrow Transplant 2009, 15:996-999.
4. Remberger M., Mattsson J., Hausenberger D., Schaffer M., et al. Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia. Eur J Haematol 2008, 80:419-428.
5. Remberger M., Mattsson J., Hassan Z., et al. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study. Bone Marrow Transplant 2008, 41:399-405.
6. Remberger M., Ringden O. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents. Transplantation 2007, 84:551-554.
7. Liu C., Lou Y., Lizee G., et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. JClin Invest 2008, 118:1165-1175.
8. Fujii H., Trudeau J.D., Teachey D.T., et al. Invivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides. Blood 2007, 109:2008-2013.
9. Lou Y., Liu C., Kim G.J., et al. Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses. JImmunol 2007, 178:1534-1541.
10. Seif A.E., Barrett D.M., Milone M., et al. Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses. Blood 2009, 114:2459-2466.
11. Reid G.S., She K., Terrett L., et al. CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response. Blood 2005, 105:3641-3647.
12. Krieg A.M. Development of TLR9 agonists for cancer therapy. JClin Invest 2007, 117:1184-1194.
13. Badie B., Berlin J.M. The future of CpG immunotherapy in cancer. Immunotherapy 2013, 5:1-3.
14. Adams S. Toll-like receptor agonists in cancer therapy. Immunotherapy 2009, 1:949-964.
15. Kreutz M., Tacken P.J., Figdor C.G. Targeting dendritic cells-why bother?. Blood 2013, 121:2836-2844.
16. Blazar B.R., Krieg A.M., Taylor P.A. Synthetic unmethylated cytosine-phosphate- guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients. Blood 2001, 98:1217-1225.
17. Fagnoni F.F., Oliviero B., Giorgiani G., et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 2004, 104:281-289.
18. Horvath R., Budinsky V., Kayserova J., et al. Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease. Clin Immunol 2009, 131:60-69.
19. Dalle J.H., Duval M., Moghrabi A., et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA- matched bone marrow. Bone Marrow Transplant 2004, 33:605-611.
20. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007, 369:1947-1954.
21. Remberger M., Sundberg B. Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation. Haematologica 2005, 90:931-938.
22. Giraud S., Dhedin N., Gary-Gouy H., et al. Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus. JInterferon Cytokine Res 2005, 25:135-143.
23. Chen W., Antonenko S., Sederstrom J.M., et al. Thrombopoietin cooperates with FLT3- ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553.
24. Olivier A., Lauret E., Gonin P., Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood 2006, 107:2694-2701.
25. Fang L., Fehse B., Engel M., et al. Antithymocyte globulin induces exvivo and invivo depletion of myeloid and plasmacytoid dendritic cells. Transplantation 2005, 79:369-371.
26. Arpinati M., Chirumbolo G., Urbini B., et al. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004, 10:106-115.
27. Merad M., Manz M.G. Dendritic cell homeostasis. Blood 2009, 113:3418-3427.
28. Duval M., Pedron B., Rohrlich P., et al. Immune reconstitution after haematopoietic transplantation with two different doses of pre-graft antithymocyte globulin. Bone Marrow Transplant 2002, 30:421-426.
29. Charrier E., Cordeiro P., Cordeau M., et al. Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol 2012, 276:114-121.
30. De Wit D., Olislagers V., Goriely S., et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004, 103:1030-1032.
31. Ringden O., Remberger M., Carlens S., et al. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation 1998, 66:620-625.
32. Meixlsperger S., Leung C.S., Ramer P.C., et al. CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 2013, 121:5033-5044.
33. Komanduri K.V., St John L.S., de L.M., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007, 110:4543-4551.
34. Charrier E., Cordeiro P., Brito R.M., et al. Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children. Bone Marrow Transplant 2013, 48:376-382.
35. Remberger M., Sundberg B. Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation. Haematologica 2004, 89:710-716.
36. Remberger M., Mattsson J., Ringden O. Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation. Pediatr Tranplant 2001, 5:285-292.
37. Tel J., Aarntzen E.H., Baba T., et al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Canc Res 2013, 73:1063-1075.
38. Bol K.F., Tel J., de Vries I.J., Figdor C.G. Naturally circulating dendritic cells to vaccinate cancer patients. Oncoimmunology 2013, 2:e23431.